title: Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density.
abstract: BACKGROUND
  Polymorphisms of the sex hormone-binding globulin (SHBG) gene are associated with differences in SHBG levels, influencing the risk for breast cancer and polycystic ovarian syndrome, but no association has been reported for osteoporosis in postmenopausal women.
  
  
  OBJECTIVE
  To determine the effect of G to A substitution in the 5'UTR (rs1799941) and the Asp356Asn (rs6259) polymorphisms of the SHBG gene on bone mineral density (BMD).
  
  
  METHODS
  This is a cross-sectional study in a university-based research center from May, 2002 to December, 2007. A total of two hundred and thirteen healthy postmenopausal Caucasian women > or = 1 year from last menstrual period participated to this study. Serum estradiol by ultrasensitive radioimmnunoassay, serum sex hormone-binding globulin by immunoradiometric assay, and urinary NTx by enzyme-linked immunoassay were measured. BMD measurements were performed by dual energy X-ray absorptiometry and genotyping by Pyrosequencing.
  
  
  RESULTS
  There were no significant differences in SHBG levels associated with either rs1799941 or rs6259. Using a p value of <0.00625 for significance, we found that subjects with the A allele (GA+AA) for the rs1799941, had a trend for lower free estradiol index (FEI) compared to the GG genotype (p=0.04). They also had significantly lower BMD at the intertrochanter (p=0.003) and trend for lower BMD at the total hip (p=0.02). There was no significant difference in FEI levels between the genotypes for the rs6259 polymorphism, but women with the Asn allele (Asp/Asn+Asn/Asn), had significantly lower BMD in the total femur (p=0.004) and intertrochanter (0.002) compared to those with the Asp/Asp genotype.
  
  
  CONCLUSIONS
  Our data suggest that polymorphisms of the SHBG gene are associated with significant differences in BMD at the proximal femur sites. Thus, genetic variations in the SHBG gene may influence BMD at the hip in postmenopausal women.
authors.affiliation: Division of Bone and Mineral Diseases at Washington University School of Medicine, Campus Box 8301, 660 South Euclid Ave. St. Louis, MO 63110, USA.
authors.forename: Nicola
authors.initials: N
authors.lastname: Napoli
authors.forename: Ana
authors.initials: A
authors.lastname: Varadharajan
authors.forename: Giovam Batista
authors.initials: GB
authors.lastname: Rini
authors.forename: Romano
authors.initials: R
authors.lastname: Del Fiacco
authors.forename: Jayasree
authors.initials: J
authors.lastname: Yarramaneni
authors.forename: Steven
authors.initials: S
authors.lastname: Mumm
authors.forename: Dennis T
authors.initials: DT
authors.lastname: Villareal
authors.forename: Reina
authors.initials: R
authors.lastname: Armamento-Villareal
mesh_terms: D020121:5' Untranslated Regions / Q000235:genetics; D015519:Bone Density / Q000235:genetics*; D004958:Estradiol / Q000097:blood*; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012738:Sex Hormone-Binding Globulin / Q000235:genetics*
chemical_list: D020121:5' Untranslated Regions; D012738:Sex Hormone-Binding Globulin; D004958:Estradiol
references.citation: Endocr Rev. 1990 Feb;11(1):80-91
references.pmid: 2180689
references.citation: J Clin Endocrinol Metab. 2006 Dec;91(12):5029-37
references.pmid: 16926255
references.citation: J Clin Invest. 1992 Dec;90(6):2464-71
references.pmid: 1469098
references.citation: J Clin Endocrinol Metab. 2003 Dec;88(12):5976-80
references.pmid: 14671199
references.citation: J Clin Endocrinol Metab. 2002 Apr;87(4):1443-50
references.pmid: 11932262
references.citation: Menopause. 2004 Mar-Apr;11(2):159-66
references.pmid: 15021445
references.citation: Int J Obes. 1991 Jul;15(7):471-8
references.pmid: 1894424
references.citation: J Natl Cancer Inst. 1995 Feb 1;87(3):190-7
references.pmid: 7707406
references.citation: N Engl J Med. 1998 Sep 10;339(11):733-8
references.pmid: 9731089
references.citation: J Clin Endocrinol Metab. 2006 Dec;91(12):4764-6
references.pmid: 17148570
references.citation: Trends Endocrinol Metab. 1995 Nov-Dec;6(9-10):298-304
references.pmid: 18406714
references.citation: BMC Med Genet. 2008 Dec 17;9:112
references.pmid: 19091090
references.citation: J Natl Cancer Inst. 1996 Mar 6;88(5):291-6
references.pmid: 8614008
references.citation: J Clin Endocrinol Metab. 2004 Mar;89(3):1240-5
references.pmid: 15001617
references.citation: Carcinogenesis. 2002 Aug;23(8):1315-20
references.pmid: 12151349
references.citation: J Clin Invest. 1996 Jan 1;97(1):14-21
references.pmid: 8550826
references.citation: Endocr Relat Cancer. 2005 Dec;12(4):1071-82
references.pmid: 16322344
references.citation: J Natl Cancer Inst. 2000 Jul 19;92(14):1151-8
references.pmid: 10904088
references.citation: Neurology. 2004 Jan 27;62(2):301-3
references.pmid: 14745075
references.citation: Br J Cancer. 2004 Jan 12;90(1):153-9
references.pmid: 14710223
references.citation: J Clin Invest. 2002 Apr;109(7):973-81
references.pmid: 11927624
references.citation: Clin Endocrinol (Oxf). 2001 Jan;54(1):81-7
references.pmid: 11167930
references.citation: Atherosclerosis. 2005 Apr;179(2):369-73
references.pmid: 15777555
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1096-101
references.pmid: 15894658
references.citation: Clin Endocrinol (Oxf). 1989 Oct;31(4):499-509
references.pmid: 2627750
references.citation: Nat Genet. 2004 Apr;36(4):388-93
references.pmid: 15052270
references.citation: J Steroid Biochem Mol Biol. 1999 Sep-Oct;70(4-6):115-21
references.pmid: 10622399
references.citation: J Clin Endocrinol Metab. 2004 Feb;89(2):917-24
references.pmid: 14764814
references.citation: Bone. 2004 Sep;35(3):682-8
references.pmid: 15336604
references.citation: J Bone Miner Res. 1998 Jul;13(7):1167-74
references.pmid: 9661081
references.citation: J Natl Cancer Inst. 2004 Jun 16;96(12):936-45
references.pmid: 15199113
references.citation: J Clin Endocrinol Metab. 2005 Mar;90(3):1550-6
references.pmid: 15613437
references.citation: J Clin Endocrinol Metab. 2004 Jul;89(7):3261-9
references.pmid: 15240601
references.citation: J Bone Miner Res. 2005 Feb;20(2):232-9
references.pmid: 15647817
references.citation: Cell. 2005 Sep 9;122(5):751-62
references.pmid: 16143106
references.citation: Breast Cancer Res Treat. 1999 Mar;54(2):101-7
references.pmid: 10424400
references.citation: J Clin Endocrinol Metab. 2005 Apr;90(4):2198-204
references.pmid: 15634719